$4.33
-0.13-2.91%
At close: Feb 11, 4:00 PM EST
$4.30
-0.16-3.59%
Pre-Market: 6:00 AM EST
Comments
Loading...
Atea Pharmaceuticals Inc Earnings Estimates
AVIRNASDAQ
Atea Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:AVIR
Atea Pharmaceuticals (AVIR) is scheduled to report Q4 earnings on March 5, 2026. Analysts estimate EPS of $-0.48 and quarterly revenue of N/A.
In the most recent quarter (Q3), Atea Pharmaceuticals reported EPS of $-0.53, missing estimates of $-0.43 by 0.23%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Atea Pharmaceuticals has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Atea Pharmaceuticals has averaged an EPS surprise of 0.16% and a revenue surprise of 0.00%.
Earnings Date
Mar 5
EPS Estimate
$-0.480
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Atea Pharmaceuticals Earnings History
Analyze the earnings history of Atea Pharmaceuticals using advanced sorting and filters.
Atea Pharmaceuticals (AVIR) Earnings Per Share
The chart below shows Atea Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $-0.53 | $-0.43 | -23.3 % |
| Q2 | 2025-08-07 | $-0.44 | $-0.43 | -2.33 % |
| Q1 | 2025-05-12 | $-0.40 | $-0.41 | 2.44 % |
| Q4 | 2025-03-06 | $-0.40 | $-0.29 | -37.9 % |
Atea Pharmaceuticals (AVIR) Revenue
The chart below shows Atea Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2022-05-10 | $0 | $3.33M | -100.0 % |
| Q4 | 2022-02-28 | $192.18M | $85.73M | 124.2 % |
| Q2 | 2021-08-12 | $60.39M | $57.99M | 4.14 % |
| Q1 | 2021-05-13 | $65.99M | $48.63M | 35.7 % |
FAQ
When is Atea Pharmaceuticals (NASDAQ:AVIR) reporting earnings?
Atea Pharmaceuticals (AVIR) is scheduled to report earnings on May 11, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
What were the latest earnings per share (EPS) for Atea Pharmaceuticals (NASDAQ:AVIR)?
The Actual EPS was $-0.53, which missed the estimate of $-0.43.
What were Atea Pharmaceuticals’s (NASDAQ:AVIR) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
